PMID- 23192608 OWN - NLM STAT- MEDLINE DCOM- 20130827 LR - 20211021 IS - 1097-4644 (Electronic) IS - 0730-2312 (Linking) VI - 114 IP - 5 DP - 2013 May TI - Osteopontin mediates macrophage chemotaxis via alpha4 and alpha9 integrins and survival via the alpha4 integrin. PG - 1194-202 LID - 10.1002/jcb.24462 [doi] AB - Osteopontin (OPN) is highly expressed by macrophages and plays a key role in the pathology of several chronic inflammatory diseases including atherosclerosis and the foreign body reaction. However, the molecular mechanism behind OPN regulation of macrophage functions is not well understood. OPN is a secreted molecule and interacts with several integrins via two domains: the RGD sequence binding to alpha(v) -containing integrins, and the SLAYGLR sequence binding to alpha(4) beta(1), alpha(4) beta(7), and alpha(9) beta(1) integrins. Here we determined the role of OPN in macrophage survival, chemotaxis, and activation state. For survival studies, OPN treated-bone marrow derived macrophages (BMDMs) were challenged with growth factor withdrawal and neutralizing integrin antibodies. We found that survival in BMDMs is mediated primarily through the alpha(4) integrin. In chemotaxis studies, we observed that migration to OPN was blocked by neutralizing alpha(4) and alpha(9) integrin antibodies. Further, OPN did not affect macrophage activation as measured by IL-12 production. Finally, the relative contributions of the RGD and the SLAYGLR functional domains of OPN to leukocyte recruitment were evaluated in an in vivo model. We generated chimeric mice expressing mutated forms of OPN in myeloid-derived leukocytes, and found that the SLAYGLR functional domain of OPN, but not the RGD, mediates macrophage accumulation in response to thioglycollate-elicited peritonitis. Collectively, these data indicate that alpha(4) and alpha(9) integrins interacting with OPN via the SLAYGLR domain play a key role in macrophage biology by regulating migration, survival, and accumulation. CI - Copyright (c) 2012 Wiley Periodicals, Inc. FAU - Lund, Susan Amanda AU - Lund SA AD - Department of Bioengineering, University of Washington, Seattle, WA 98109, USA. FAU - Wilson, Carole L AU - Wilson CL FAU - Raines, Elaine W AU - Raines EW FAU - Tang, Jingjing AU - Tang J FAU - Giachelli, Cecilia M AU - Giachelli CM FAU - Scatena, Marta AU - Scatena M LA - eng GR - P01 HL018645/HL/NHLBI NIH HHS/United States GR - HL-018645/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (Integrin alpha Chains) RN - 0 (Thioglycolates) RN - 0 (integrin alpha9) RN - 106441-73-0 (Osteopontin) RN - 143198-26-9 (Integrin alpha4) SB - IM MH - Amino Acid Sequence MH - Animals MH - Bone Marrow Cells/cytology MH - Cell Survival MH - *Chemotaxis MH - Cytokines/biosynthesis MH - Inflammation Mediators/metabolism MH - Integrin alpha Chains/*metabolism MH - Integrin alpha4/*metabolism MH - Macrophages/*cytology/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Molecular Sequence Data MH - Osteopontin/chemistry/*metabolism MH - Peritonitis/metabolism/pathology MH - Phenotype MH - Protein Structure, Tertiary MH - Signal Transduction MH - Structure-Activity Relationship MH - Thioglycolates EDAT- 2012/11/30 06:00 MHDA- 2013/08/28 06:00 CRDT- 2012/11/30 06:00 PHST- 2011/11/14 00:00 [received] PHST- 2012/11/12 00:00 [accepted] PHST- 2012/11/30 06:00 [entrez] PHST- 2012/11/30 06:00 [pubmed] PHST- 2013/08/28 06:00 [medline] AID - 10.1002/jcb.24462 [doi] PST - ppublish SO - J Cell Biochem. 2013 May;114(5):1194-202. doi: 10.1002/jcb.24462.